Serum albumin: Touchstone or totem?

Anaesthesia

Volumn 53, Issue 8, 1998, Pages 789-803

  Margarson, M P ^a   Soni, N ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Protein, albumin

Indexed keywords

SERUM ALBUMIN;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD VESSEL PERMEABILITY; COLLOID; DIAGNOSTIC VALUE; HUMAN; HYPOALBUMINEMIA; PROGNOSIS;

ACUTE-PHASE REACTION; ALBUMINS; BIOLOGICAL MARKERS; BLOOD COAGULATION; CELL MEMBRANE PERMEABILITY; FEMALE; HUMANS; OSMOTIC PRESSURE; POSTOPERATIVE COMPLICATIONS; PRE-ECLAMPSIA; PREGNANCY; SERUM ALBUMIN; STARVATION;

EID: 0031818148     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1998.00438.x     Document Type: Article

References (108)

1. Madison J, Galliano M, Watkins S et al. Genetic variants of human serum albumin in Italy: point mutants and a carboxy-terminal variant. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 6476-80.
2. Takagi M, Ogato K. Direct evidence for albumin biosynthesis by membrane bound polysomes in rat liver. Biochemical Biophysical Research Communications 1968; 33: 55-60.
3. Redman CM. Biosynthesis of serum proteins and ferritin by free and attached ribosomes of rat liver. Journal of Biological Chemistry 1969; 244: 4308-15.
4. Pietrangelo A, Panduro A, Chowdhury JR, Shafritz DA. Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. Journal of Clinical Investigation 1992; 89: 1755-60.
5. Kimball SR, Horetsky RL, Jefferson LS. Hormonal regulation of albumin gene expression in primary cultures of rat hepatocytes. American Journal of Physiology 1995; 268: E6-14.
6. Zachwieja JJ, Bier DM, Yarasheski KE. Growth hormone administration in older adults: effects on albumin synthesis. American Journal of Physiology 1994; 266: E840-4.
7. Hutson SM, Stinson-Fisher C, Shiman R, Jefferson LS. Regulation of albumin synthesis by hormones and amino acids in primary cultures of rat hepatocytes. American Journal of Physiology 1987; 260: R177-84.
8. Tucker VL, Simanonok KE, Renkin EM. Tissue-specific effects of physiological ANP infusion on blood-tissue albumin transport. American Journal of Physiology 1992; 263: R945-53.
9. Parving HH, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circulation Research 1973; 32: 643-51.
10. Hill PG. The measurement of albumin in serum and plasma. Annals Clinical Biochemistry 1985; 22: 565-78.
11. Bullock D. UK NEQAS for clinical chemistry, Birmingham 1997; Personal communication.
12. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Danish Medical Bulletin 1990; 37: 57-83.
13. Doweiko JP, Bistrian BR. The effect of glycosylated albumin on platelet aggregation. Journal of Parenteral and Enteral Nutrition 1994; 18: 516-20.
14. Guyton AC, Hall JE, eds. Human Physiology and Mechanisms of Disease. Philadelphia: WB Saunders, 1997.
15. Taylor AE, Parker JC, Allison RC, Perry M, Barman S. Capillary exchange of fluid and protein. In: Carlson RW, Geheb MA, eds. Principles and Practice of Medical Intensive Care. Philadelphia: WB Saunders, 1993.
16. Halliwell B. Albumin - an important extracellular antioxidant. Biochemical Pharmacology 1988; 37: 569-71.
17. Strubelt O, Younes M, Li Y. Protection by albumin against ischaemia- and hypoxia-induced hepatic injury. Pharmacology and Toxicology 1994; 75: 280-4.
18. Quinlan GJ, Mumby S. Personal communication.
19. Dietrich G, Haupt W, Kretschmer V. [Disorders of primary hemostasis caused by albumin infusion in hemodilution]. Beitrage zur Infusionstherapie 1991; 28: 331-4.
20. Simon DI, Stamler JS, Jaraki O et al. Anti-platelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arteriosclerosis and Thrombosis 1993; 13: 791-9.
21. Mulvihill JN, Faradji A, Oberling F, Cazenave JP. Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Journal of Biomedical Materials Research 1990; 24: 155-63.
22. Marelli D, Paul A, Samson R, Edgell D, Angood P, Chiu RC. Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome? A prospective randomized study. Journal of Thoracic and Cardiovascular Surgery 1989; 98: 751-6.
23. Tollofsrud S, Svennevig JL, Breivik H et al. Fluid balance and pulmonary function during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline or albumin. Acta Anaesthesiologica Scandinavica 1995; 39: 671-7.
24. Ramirez-Vick J, Vargas FF. Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin. American Journal of Physiology 1993; 264: H1382-7.
25. Qiao R, Siflinger-Birnboim A, Lum H, Tiruppathi C, Malik AB. Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. American Journal of Physiology 1993; 265: C439-46.
26. Lum H, Siflinger-Birnboim A, Blumenstock F, Malik AB. Serum albumin decreases transendothelial permeability to macromolecules. Microvascular Research 1991; 42: 91-102.
27. Bent-Hansen L. Whole body capillary exchange of albumin. Acta Physiologica Scandinavica 1991; S603: 5-10.
28. Zawieja DC. Lymphatic microcirculation. Microcirculation 1996; 3: 241-3.
29. Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW. Analbuminemia: three cases resulting from different point mutations in the albumin gene. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 9417-21.
30. Keys A, Brozek J, Henschel A, Mickelson O, Taylor HL. The Biology of Human Starvation. The University of Minnesota Press, 1950.
31. Broom J, Fraser MH, McKenzie K, Miller JB, Fleck A. The protein metabolic response to short-term starvation in man. Clinical Nutrition 1986; 5: 63-5.
32. Rothschild MA, Oratz M, Schreiber SS. Effects of nutrition and alcohol on albumin synthesis. Alcoholism, Clinical and Experimental Research 1983; 7: 28-30.
33. McClave SA, Mitoraj TE, Thielmeier KA, Greenburg RA. Differentiating subtypes (hypoalbuminemic vs marasmic) of protein-calorie malnutrition: incidence and clinical significance in a university hospital setting. Journal of Parenteral and Enteral Nutrition 1992; 16: 337-42.
34. Jeejeebhoy KN. Nutrition and serum albumin levels (editorial). Nutrition 1994; 10: 353.
35. Rothschild MA, Oratz M, Zimmon D, Schreiber SS, Weiner I, van Laneghem A. Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-14C. Journal of Clinical Investigation 1969; 48: 344-50.
36. Brenner BM, Meyer TW, Hofstetter TH. Dietary protein intake and the progressive nature of kidney disease. New England Journal of Medicine 1982; 307: 652-9.
37. Brown MA, Zammit VC, Lowe SA. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clinical Science 1989; 77: 599-604.
38. Bhatia RK, Bottoms SF, Abdelaziz AS, Norman GS, Mammen EF, Sokol RJ. Mechanisms for reduced colloid osmotic pressure in pre-eclampsia. American Journal of Obstetrics and Gynecology 1987; 157: 106-8.
39. Arbogast BW, Leeper SC, Merrick RD, Olive KE, Taylor RN. Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet 1994; 343: 340-41.
40. Stratta P, Canavese C, Dogliani M et al. Repeated albumin infusions do not lower blood pressure in pre-eclampsia. Clinical Nephrology 1991; 36: 234-39.
41. Ballmer-Weber BK, Dummer R, Kung E, Burg G, Ballmer PE. Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool. British Journal of Cancer 1995; 71: 78-82.
42. Myers MA. Aspects of the acute phase response. PhD thesis, University of London, 1987.
43. Huang Y, Shinzawa H, Togashi H et al. Interleukin-6 down-regulates expressions of the aldolase B and albumin genes through a pathway involving the activation of tyrosine kinase. Archives of Biochemistry & Biophysics 1995; 320: 203-9.
44. Dahn MS, Mitchell RA, Lange P, Smith S, Jacobs LA. Hepatic metabolic response to injury and sepsis. Surgery 1995; 117: 520-2.
45. Shakespeare PG, Coombes EJ, Hambleton J, Furness D. Proteinuria after burn injury. Annals of Clinical Biochemistry 1981; 18: 353-60.
46. Gottschlich MM, Baumer T, Jenkins M, Khoury J, Warden GD. The prognostic value of nutritional and inflammatory indices in patients with burns. Journal of Burn Care and Rehabilitation 1992; 13: 105-13.
47. Barton RN (ed). Trauma and its metabolic problems. British Medical Bulletin 1985; 00: 41-3.
48. Fleck A, Raines G, Hawker F et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985; 1: 781-4.
49. Mullen JL, Gertner MH, Buzby GP, Goodhart GL, Rosato EF. Implications of malnutrition in the surgical patient. Archives of Surgery 1979; 114: 121-5.
50. Smeets HJ, Kievet J, Dulfer FT, Hermans J, Moolenaar AJ. Analysis of post-operative hypoalbuminaemia: a clinical study. International Surgery 1994; 79: 152-7.
51. Hoye RC, Bennett SH, Geelhoed GW, Gorschboth C. Fluid volume and albumin kinetics occurring with major surgery. Journal of the American Medical Association 1972; 222: 1255-61.
52. Woods MS, Kelley H. Oncotic pressure, albumin and ileus: The effect of albumin replacement on postoperative ileus. The American Surgeon 1993; 59: 758-63.
53. Suttorp N, Hessz T, Seeger W et al. Bacterial exotoxins and endothelial permeability for water and albumin in vitro. American Journal of Physiology 1988; 255: C368-76.
54. Kurose I, Anderson DC, Miyasaka M et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circulation Research 1994; 74: 336-43.
55. Whicher J, Spence C. When is serum albumin worth measuring? Annals of Clinical Biochemistry 1987; 24: 572-80.
56. Bradley JA, Cunningham KJ, Jackson VJ, Hamilton DNH, Ledingham IMcA. Serum protein levels in critically ill surgical patients. Intensive Care Medicine 1981; 7: 291-5.
57. McCluskey A, Thomas AN, Bowles BJM, Kishen R. The prognostic value of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 1996; 51: 724-7.
58. Erstad BL. Serum albumin concentrations: who needs them? Annals of Pharmacotherapy 1992; 26: 1134-8.
59. Brown RO, Bradley JE, Bekemeyer WB, Luther RW. Effect of albumin supplementation during parenteral nutrition on hospital mortality. Critical Care Medicine 1988; 16: 1177-82.
60. Grootendorst AF, van Wilgenburg MG, de Laat PH, van der Hoven B. Albumin abuse in intensive care medicine. Intensive Care Medicine 1989; 14: 554-7.
61. Stockwell MA, Soni N, Riley B. Colloid solutions in the critically ill. Anaesthesia 1992; 47: 3-6.
62. Foley EF, Borlase BC, Dzik WH, Bistrian BR, Benotti PN. Albumin supplementation in the critically ill. Archives of Surgery 1990; 125: 739-42.
63. Wojtysiak SL, Brown RO, Roberson D, Powers DA, Kudsk KA. Effect of hypoalbuminaemia and parenteral nutrition on free water excretion and electrolyte-free water resorption. Critical Care Medicine 1992; 20: 164-9.
64. Golub R, Sorrento JJ, Cantu R, Nierman DM, Moideen A, Stein HD. Efficacy of albumin supplementation in the surgical intensive care unit: a prospective randomized study. Critical Care Medicine 1994; 22: 613-19.
65. Rubin H, Carlson S, DeMeo M, Ganger D, Craig RM. Randomized, double-blind study of intravenous human albumin in hypoalbuminemic patients receiving total parenteral nutrition. Critical Care Medicine 1997; 25: 249-52.
66. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13: 707-713.
67. Kaysen GA. In: Kopple JD, Massey SG, eds. Nutritional Management of Renal Disease. Baltimore: Williams and Wilkins, 1997.
68. Akcicek F, Yalniz T, Basci A, Ok E, Dorhout Mees EJ. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? British Medical Journal 1995; 310: 162-3.
69. Greenhalgh DG, Housinger TA, Kagan RJ et al. Maintenance of serum albumin levels in pediatric burn patients: a prospective, randomized trial. Journal of Trauma 1995; 39: 67-73.
70. Gammelgard B, Sandberg E. Aluminium and nickel in human albumin solutions. Journal of Trace Elements and Electrolytes in Health and Disease 1989; 3: 39-42.
71. Quinlan GJ, Coudray C, Hubbard A, Gutteridge JMC. Vanadium and copper in clinical solutions of albumin and their potential to damage protein structure. Journal of Pharmaceutical Science 1992; 81: 611-4.
72. Koppel C, Baudisch H, Ibe K. Inadvertent metal loading of critically ill patients with acute renal failure by human albumin solution infusion therapy. Journal of Toxicology & Clinical Toxicology 1988; 26: 337-56.
73. Zoli M, Cordiani MR, Marchesini G et al. Prognostic indicators in compensated cirrhosis. American Journal of Gastroenterology 1991; 86: 1508-13.
74. Sugimura T, Tsuji Y, Sakamoto M et al. Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s. Journal of Gastroenterology and Hepatology 1994; 9: 154-61.
75. Lacaine F, LaMuraglia GM, Malt RA. Prognostic factors in survival after portasystemic shunts. Multivariate analysis. Annals of Surgery 1985; 202: 729-34.
76. Chou FF, Sheen Chen SM, Chen YS, Chen MC, Chen FC, Tai DI. Prognostic factors for pyogenic abscess of the liver. Journal of the American College of Surgeons 1994; 179: 727-32.
77. Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology 1993; 105: 1865-76.
78. Su CH, Tsay SH, Wu CC et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Annals of Surgery 1996; 223: 384-94.
79. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77: 2217-22.
80. Anderson CF, Wochos DN. The utility of serum albumin values in the nutritional assessment of hospitalized patients. Mayo Clinic Proceedings 1982; 57: 181-4.
81. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis-predictors and correlations with outcomes. Journal of the American Society of Nephrologists 1993; 3: 1501-7.
82. Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrology Dialysis Transplantation 1996; 11: 2192-201.
83. Gottschlich MM, Baumer T, Jenkins M, Khoury J, Warden GD. The prognostic value of nutritional and inflammatory indices in patients with burns. Journal of Burn Care Rehabilitation 1992; 13: 105-13.
84. Steinberg J, Erlichman C, Gadalla T, Fine S, Wong A. Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. European Journal of Cancer 1992; 28A: 1817-20.
85. Kemeny N, Niedzwiecki D, Shurgot B, Oderman P. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 1989; 63: 742-7.
86. Parker D, Bradley C, Bogle SM et al. Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer. British Journal of Obstetrics and Gynaecology 1994; 101: 888-93.
87. Warwick J, Kehoe S, Earl H, Luesley D, Redman C, Chan KK. Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials. British Journal of Cancer 1995; 72: 1513-7.
88. Muers MF, Shevlin P, Brown J. Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive model. Thorax 1996; 51: 894-902.
89. Johnson PW, Joel SP, Love S et al. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer. British Journal of Cancer 1993; 67: 760-6.
90. Yamkanaka H, Nishi M, Kanemaki T, Hosoda N, Hioki K, Yamamoto M. Preoperative nutritional assessment to predict postoperative complication in gastric cancer patients. Journal of Parenteral and Enteral Nutrition 1989; 13: 286-91.
91. Lee YT. Biochemical and hematological tests in patients with breast carcinoma: correlations with extent of disease, sites of relapse, and prognosis. Journal of Surgical Oncology 1985; 29: 242-8.
92. Amurawaiye EO, Brown RA. Acute pancreatitis - 30 years' experience at a teaching hospital. Canadian Journal of Surgery 1991; 35: 137-43.
93. Falconer JS, Fearon KC, Ross JA et al. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995; 75: 2077-82.
94. Oshitani N, Kitano A, Fukushima R et al. Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment. Digestion 1990; 46: 107-13.
95. Sirott MN, Bajorin DF, Wong GY et al. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 1993; 72: 3091-8.
96. Levis A, Ficara F, Marmont F, De Crescenzo A, Resegotti L. Prognostic significance of serum albumin in chronic lymphocytic leukemia. Haematologica 1991; 76: 113-9.
97. Gandarillas MA, Conde E, Mazorra F et al. Research on prognostic factors in large-cell lymphomas. Medicina Clinica (Barcelona) 1995; 104: 601-7.
98. Blade J, Rozman C, Cervantes F, Reverter JC, Montserrat E. A new prognostic system for multiple myeloma based on easily available parameters. British Journal of Haematology 1989; 72: 507-11.
99. Brown MA, Buddle ML. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Medical Journal of Australia 1996; 165: 360-5.
100. Riquelme R, Torres A, El Ebiary M et al. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. American Journal of Respiratory and Critical Care Medicine 1996; 154: 1450-5.
101. Hedlund JU, Ortqvist AB, Kalin ME, Granath F. Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax 1993; 48: 785-9.
102. Papadakis MA, Browner WS. Prognosis of noncardiac medical patients receiving mechanical ventilation in a veterans hospital. American Journal of Medicine 1987; 83: 687-92.
103. Ewig S, Bauer T, Schneider C et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. European Respiratory Journal 1995; 8: 1548-53.
104. Hoen B, Viel JF, Maignan M et al. Prognostic factors of Pneumocystis carinii pneumonia in AIDS. Presse Medicale (Paris) 1996; 25: 443-8.
105. Wachter RM, Russi MB, Bloch DA, Hopewell PC, Luce JM. Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units. American Review of Respiratory Disease 1991; 143: 251-6.
106. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. Prognostic criteria in Clostridium difficile colitis. American Journal of Gastroenterology 1996; 91: 460-4.
107. Schneider R, Lang BA, Reilly BJ et al. Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. Journal of Pediatrics 1992; 120: 200-5.
108. Kirk JL Jr, Greenfield RA, Slease RB, Epstein RB. Analysis of early infectious complications after autologous bone marrow transplantation. Cancer 1988; 62: 2445-50.